The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Adagene Inc(NASDAQ:ADAG)


Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. Its products include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase Ib clinical trials for the ...
Website: http://www.adagene.com
Founded: 2011
CEO: Peter Luo
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Adagene Days Payable Outstanding ttm (DPO)
Adagene Days Receivable Outstanding ttm (DSO)
Adagene Op Cashflow Per Share ttm
Adagene Free Cashflow Per Share ttm
Adagene Cash Per Share ttm
Adagene P/S ratio ttm
Adagene (GAAP) P/E ratio ttm
Adagene P/B ratio ttm
No extra charts and metrics for this ticker.